Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Total Debt (2016 - 2025)

Historic Total Debt for Apyx Medical (APYX) over the last 14 years, with Q3 2025 value amounting to $34.6 million.

  • Apyx Medical's Total Debt rose 222.73% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.6 million, marking a year-over-year increase of 222.73%. This contributed to the annual value of $33.9 million for FY2024, which is 213.35% up from last year.
  • Per Apyx Medical's latest filing, its Total Debt stood at $34.6 million for Q3 2025, which was up 222.73% from $34.4 million recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's Total Debt peaked at $34.6 million during Q3 2025, and registered a low of $8.8 million during Q1 2023.
  • Over the past 3 years, Apyx Medical's median Total Debt value was $33.6 million (recorded in 2024), while the average stood at $27.1 million.
  • Within the past 5 years, the most significant YoY rise in Apyx Medical's Total Debt was 28056.5% (2024), while the steepest drop was 213.35% (2024).
  • Apyx Medical's Total Debt (Quarter) stood at $33.2 million in 2023, then increased by 2.13% to $33.9 million in 2024, then grew by 2.11% to $34.6 million in 2025.
  • Its Total Debt was $34.6 million in Q3 2025, compared to $34.4 million in Q2 2025 and $34.1 million in Q1 2025.